Search

Author/Creator Heaney, Mark L.

1. A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis. Issue 5 (2nd November 2016)

Authors:
Arceci, Robert J.; Allen, Carl E.; Dunkel, Ira J.; Jacobsen, Eric; Whitlock, James; Vassallo, Robert; Morris, Shannon R.; Portnoy, Alison; Reedy, Beth Ann; Smith, Deborah A.; Noble, Robert; Murnane, Amy; Cornfeld, Mark; Rodriguez‐Galindo, Carlos; Heaney, Mark L.; McClain, Kenneth; Vaiselbuh, Sarah
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 5(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera. Issue 6 (11th June 2022)

Authors:
Tremblay, Douglas; Srisuwananukorn, Andrew; Ronner, Lukas; Podoltsev, Nikolai; Gotlib, Jason; Heaney, Mark L.; Kuykendall, Andrew; O'Connell, Casey L.; Shammo, Jamile M.; Fleischman, Angela; Mesa, Ruben; Yacoub, Abdulraheem; Hoffman, Ronald; Moshier, Erin; Zubizarreta, Nicole; Mascarenhas, John
Journal:
HemaSphere
Issue:
Volume 6:Issue 6(2022)
Page Start:
e721
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗